Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 3 | 2023 | 161 | 1.680 |
Why?
|
Colorectal Surgery | 3 | 2022 | 22 | 1.570 |
Why?
|
Quality Improvement | 9 | 2023 | 429 | 1.340 |
Why?
|
Postoperative Complications | 11 | 2023 | 2207 | 1.260 |
Why?
|
Rectum | 4 | 2023 | 146 | 1.130 |
Why?
|
Colectomy | 5 | 2022 | 167 | 1.070 |
Why?
|
Rectal Neoplasms | 3 | 2024 | 116 | 1.050 |
Why?
|
Analgesics, Opioid | 3 | 2023 | 413 | 0.980 |
Why?
|
Prescription Drug Misuse | 1 | 2023 | 13 | 0.920 |
Why?
|
Catastrophization | 1 | 2022 | 7 | 0.850 |
Why?
|
Colonic Neoplasms | 3 | 2022 | 558 | 0.830 |
Why?
|
Sexism | 1 | 2022 | 51 | 0.820 |
Why?
|
Digestive System Surgical Procedures | 3 | 2022 | 120 | 0.810 |
Why?
|
Anus Diseases | 1 | 2020 | 14 | 0.780 |
Why?
|
Paget Disease, Extramammary | 1 | 2020 | 8 | 0.760 |
Why?
|
Colon | 2 | 2021 | 496 | 0.750 |
Why?
|
Crohn Disease | 2 | 2020 | 730 | 0.750 |
Why?
|
Anus Neoplasms | 1 | 2020 | 30 | 0.740 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2021 | 66 | 0.740 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2020 | 48 | 0.730 |
Why?
|
Insurance Coverage | 1 | 2021 | 117 | 0.720 |
Why?
|
Postoperative Care | 2 | 2020 | 221 | 0.710 |
Why?
|
Home Health Nursing | 1 | 2017 | 2 | 0.600 |
Why?
|
Ileostomy | 1 | 2017 | 30 | 0.590 |
Why?
|
Patient Selection | 2 | 2022 | 686 | 0.590 |
Why?
|
Fecal Microbiota Transplantation | 2 | 2021 | 62 | 0.570 |
Why?
|
Renal Insufficiency | 1 | 2016 | 114 | 0.550 |
Why?
|
Aftercare | 1 | 2017 | 85 | 0.550 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2022 | 549 | 0.530 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 145 | 0.530 |
Why?
|
Pouchitis | 1 | 2015 | 44 | 0.530 |
Why?
|
Humans | 35 | 2024 | 86678 | 0.510 |
Why?
|
Patient Readmission | 2 | 2019 | 329 | 0.490 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 184 | 0.480 |
Why?
|
Risk Assessment | 2 | 2020 | 2264 | 0.450 |
Why?
|
Length of Stay | 5 | 2022 | 704 | 0.430 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 938 | 0.410 |
Why?
|
Databases, Factual | 3 | 2021 | 816 | 0.410 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2012 | 237 | 0.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2438 | 0.360 |
Why?
|
Practice Patterns, Physicians' | 3 | 2023 | 584 | 0.350 |
Why?
|
United States | 9 | 2024 | 6681 | 0.340 |
Why?
|
Retrospective Studies | 9 | 2022 | 8496 | 0.340 |
Why?
|
Perioperative Care | 2 | 2022 | 161 | 0.330 |
Why?
|
Sepsis | 2 | 2023 | 306 | 0.330 |
Why?
|
Surgeons | 2 | 2023 | 238 | 0.330 |
Why?
|
Short Bowel Syndrome | 2 | 2022 | 37 | 0.310 |
Why?
|
Aged, 80 and over | 4 | 2021 | 6513 | 0.280 |
Why?
|
Risk Factors | 6 | 2022 | 5420 | 0.280 |
Why?
|
Pain, Postoperative | 3 | 2022 | 240 | 0.270 |
Why?
|
Laparoscopy | 3 | 2022 | 754 | 0.270 |
Why?
|
Hospitals | 3 | 2023 | 294 | 0.270 |
Why?
|
Logistic Models | 2 | 2021 | 1188 | 0.260 |
Why?
|
Middle Aged | 10 | 2021 | 25040 | 0.240 |
Why?
|
Prescriptions | 1 | 2023 | 21 | 0.230 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 39 | 0.230 |
Why?
|
Urinary Tract Infections | 1 | 2023 | 76 | 0.230 |
Why?
|
Female | 12 | 2021 | 44550 | 0.220 |
Why?
|
Male | 11 | 2021 | 40988 | 0.210 |
Why?
|
Aged | 7 | 2021 | 18423 | 0.210 |
Why?
|
Enterostomy | 1 | 2020 | 3 | 0.200 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2020 | 15 | 0.200 |
Why?
|
Mental Health | 1 | 2022 | 162 | 0.190 |
Why?
|
Ligation | 1 | 2020 | 51 | 0.190 |
Why?
|
Fitness Trackers | 1 | 2020 | 5 | 0.190 |
Why?
|
Clinical Alarms | 1 | 2020 | 16 | 0.190 |
Why?
|
Steroids | 1 | 2022 | 177 | 0.190 |
Why?
|
Adult | 8 | 2021 | 25659 | 0.190 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 1673 | 0.190 |
Why?
|
Leadership | 1 | 2022 | 134 | 0.190 |
Why?
|
Early Ambulation | 1 | 2020 | 25 | 0.190 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.190 |
Why?
|
Organizational Innovation | 1 | 2020 | 41 | 0.190 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2020 | 53 | 0.180 |
Why?
|
Margins of Excision | 1 | 2020 | 39 | 0.180 |
Why?
|
Drainage | 1 | 2020 | 157 | 0.180 |
Why?
|
Anal Canal | 1 | 2020 | 89 | 0.180 |
Why?
|
Self Care | 1 | 2020 | 164 | 0.170 |
Why?
|
Proctocolectomy, Restorative | 1 | 2020 | 87 | 0.170 |
Why?
|
Referral and Consultation | 1 | 2022 | 328 | 0.170 |
Why?
|
Operating Rooms | 1 | 2020 | 126 | 0.170 |
Why?
|
Infection Control | 1 | 2020 | 115 | 0.170 |
Why?
|
Foundations | 1 | 2019 | 25 | 0.170 |
Why?
|
Simulation Training | 1 | 2020 | 88 | 0.170 |
Why?
|
Mental Disorders | 1 | 2022 | 371 | 0.170 |
Why?
|
Clostridium Infections | 1 | 2021 | 125 | 0.160 |
Why?
|
Biological Products | 1 | 2020 | 143 | 0.160 |
Why?
|
Quality of Health Care | 1 | 2022 | 381 | 0.160 |
Why?
|
Research Support as Topic | 1 | 2019 | 80 | 0.160 |
Why?
|
Surgical Flaps | 1 | 2020 | 241 | 0.160 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 468 | 0.160 |
Why?
|
Clinical Protocols | 1 | 2019 | 156 | 0.160 |
Why?
|
Neoplasm Staging | 2 | 2022 | 1939 | 0.160 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 552 | 0.160 |
Why?
|
Cecum | 1 | 2018 | 68 | 0.160 |
Why?
|
Intestinal Perforation | 1 | 2018 | 34 | 0.160 |
Why?
|
Patient Care Team | 1 | 2020 | 280 | 0.160 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 257 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 861 | 0.150 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 860 | 0.150 |
Why?
|
Critical Care | 1 | 2021 | 370 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2022 | 372 | 0.150 |
Why?
|
Suburethral Slings | 1 | 2018 | 73 | 0.150 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 683 | 0.150 |
Why?
|
Age Factors | 1 | 2021 | 1852 | 0.140 |
Why?
|
Dyspnea | 1 | 2016 | 73 | 0.140 |
Why?
|
Serum Albumin | 1 | 2016 | 130 | 0.140 |
Why?
|
Emergencies | 1 | 2016 | 113 | 0.140 |
Why?
|
Hospital Costs | 1 | 2017 | 107 | 0.140 |
Why?
|
Area Under Curve | 1 | 2016 | 334 | 0.140 |
Why?
|
Colonoscopy | 1 | 2018 | 267 | 0.140 |
Why?
|
Urinary Incontinence, Stress | 1 | 2018 | 192 | 0.140 |
Why?
|
Incidence | 2 | 2019 | 1578 | 0.140 |
Why?
|
Economics, Hospital | 1 | 2015 | 11 | 0.130 |
Why?
|
Creatinine | 1 | 2016 | 339 | 0.130 |
Why?
|
Transanal Endoscopic Surgery | 1 | 2015 | 2 | 0.130 |
Why?
|
Ulcer | 1 | 2015 | 36 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2015 | 41 | 0.130 |
Why?
|
Treatment Outcome | 2 | 2020 | 7998 | 0.130 |
Why?
|
Carcinoid Tumor | 1 | 2015 | 42 | 0.130 |
Why?
|
Inflammation | 1 | 2020 | 923 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Societies, Medical | 1 | 2019 | 573 | 0.130 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 296 | 0.130 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 81 | 0.130 |
Why?
|
Acute Disease | 1 | 2016 | 826 | 0.130 |
Why?
|
Odds Ratio | 1 | 2016 | 680 | 0.130 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 747 | 0.130 |
Why?
|
Anesthesiology | 1 | 2016 | 157 | 0.120 |
Why?
|
Internship and Residency | 1 | 2024 | 1010 | 0.120 |
Why?
|
Hepatectomy | 1 | 2015 | 166 | 0.120 |
Why?
|
Preoperative Care | 1 | 2016 | 397 | 0.120 |
Why?
|
Pilot Projects | 1 | 2017 | 840 | 0.120 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2022 | 1686 | 0.120 |
Why?
|
Prospective Studies | 1 | 2022 | 4214 | 0.110 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 711 | 0.110 |
Why?
|
Sex Factors | 1 | 2016 | 1055 | 0.110 |
Why?
|
Adenoma | 1 | 2015 | 237 | 0.110 |
Why?
|
Intestine, Large | 1 | 2012 | 16 | 0.110 |
Why?
|
Intestinal Fistula | 1 | 2012 | 30 | 0.110 |
Why?
|
Chronic Disease | 1 | 2015 | 973 | 0.100 |
Why?
|
Abdominal Abscess | 1 | 2012 | 22 | 0.100 |
Why?
|
Infliximab | 1 | 2012 | 151 | 0.100 |
Why?
|
Georgia | 2 | 2022 | 34 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 213 | 0.100 |
Why?
|
Intestine, Small | 1 | 2012 | 303 | 0.090 |
Why?
|
Follow-Up Studies | 1 | 2017 | 3642 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 243 | 0.090 |
Why?
|
Reoperation | 1 | 2012 | 597 | 0.090 |
Why?
|
Recurrence | 1 | 2012 | 1139 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2009 | 152 | 0.080 |
Why?
|
Protein Kinases | 1 | 2009 | 209 | 0.080 |
Why?
|
Hypertension | 1 | 2016 | 1142 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 865 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2015 | 1169 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 977 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 1169 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 1376 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2009 | 558 | 0.070 |
Why?
|
Young Adult | 2 | 2020 | 5980 | 0.070 |
Why?
|
Adolescent | 2 | 2020 | 8984 | 0.060 |
Why?
|
Data Accuracy | 1 | 2024 | 31 | 0.060 |
Why?
|
Risk Adjustment | 1 | 2023 | 39 | 0.060 |
Why?
|
Accreditation | 1 | 2024 | 60 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2009 | 1458 | 0.060 |
Why?
|
Syndrome | 1 | 2023 | 446 | 0.050 |
Why?
|
Nutritional Status | 1 | 2022 | 83 | 0.050 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 267 | 0.050 |
Why?
|
Postoperative Period | 1 | 2022 | 303 | 0.050 |
Why?
|
Child | 1 | 2012 | 6928 | 0.050 |
Why?
|
Medical Audit | 1 | 2020 | 41 | 0.050 |
Why?
|
Personal Protective Equipment | 1 | 2020 | 32 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2022 | 298 | 0.040 |
Why?
|
Patient Compliance | 1 | 2020 | 228 | 0.040 |
Why?
|
Financing, Government | 1 | 2019 | 23 | 0.040 |
Why?
|
Federal Government | 1 | 2019 | 29 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 122 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 29 | 0.040 |
Why?
|
Publishing | 1 | 2019 | 90 | 0.040 |
Why?
|
Elective Surgical Procedures | 1 | 2019 | 116 | 0.040 |
Why?
|
General Surgery | 1 | 2020 | 229 | 0.040 |
Why?
|
Incidental Findings | 1 | 2018 | 95 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
Registries | 1 | 2020 | 703 | 0.040 |
Why?
|
Surveys and Questionnaires | 1 | 2024 | 2504 | 0.030 |
Why?
|
Pneumonia, Aspiration | 1 | 2015 | 19 | 0.030 |
Why?
|
Rectal Diseases | 1 | 2015 | 24 | 0.030 |
Why?
|
Abscess | 1 | 2015 | 91 | 0.030 |
Why?
|
Operative Time | 1 | 2015 | 127 | 0.030 |
Why?
|
Reference Standards | 1 | 2015 | 159 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 455 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 2601 | 0.030 |
Why?
|
Time Factors | 1 | 2020 | 5214 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 3362 | 0.020 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2009 | 13 | 0.020 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 29 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2009 | 94 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2009 | 143 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 95 | 0.020 |
Why?
|
Sirolimus | 1 | 2009 | 170 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 182 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2009 | 459 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2009 | 2819 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 777 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 3095 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 1565 | 0.010 |
Why?
|
Mice | 1 | 2009 | 11356 | 0.010 |
Why?
|
Animals | 1 | 2009 | 26590 | 0.010 |
Why?
|